A detailed history of Jacobs & CO transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Jacobs & CO holds 25,193 shares of LH stock, worth $5.82 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
25,193
Previous 24,643 2.23%
Holding current value
$5.82 Million
Previous $5.02 Million 12.26%
% of portfolio
0.56%
Previous 0.53%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

BUY
$199.35 - $236.0 $109,642 - $129,800
550 Added 2.23%
25,193 $5.63 Million
Q2 2024

Jul 12, 2024

BUY
$192.5 - $216.35 $195,002 - $219,162
1,013 Added 4.29%
24,643 $5.02 Million
Q1 2024

Apr 12, 2024

BUY
$209.01 - $232.56 $88,620 - $98,605
424 Added 1.83%
23,630 $5.16 Million
Q2 2023

Jul 11, 2023

SELL
$211.93 - $241.33 $127,158 - $144,798
-600 Reduced 2.52%
23,206 $5.6 Million
Q1 2023

Apr 17, 2023

SELL
$213.32 - $257.83 $150,817 - $182,285
-707 Reduced 2.88%
23,806 $5.46 Million
Q4 2022

Jan 13, 2023

SELL
$203.72 - $248.97 $8,148 - $9,958
-40 Reduced 0.16%
24,513 $5.77 Million
Q3 2022

Oct 11, 2022

SELL
$204.81 - $262.19 $23,553 - $30,151
-115 Reduced 0.47%
24,553 $5.03 Million
Q2 2022

Jul 19, 2022

SELL
$213.86 - $277.87 $415,743 - $540,179
-1,944 Reduced 7.3%
24,668 $5.78 Million
Q1 2022

Apr 14, 2022

SELL
$259.82 - $298.18 $41,571 - $47,708
-160 Reduced 0.6%
26,612 $7.02 Million
Q4 2021

Jan 21, 2022

SELL
$271.6 - $314.21 $93,158 - $107,774
-343 Reduced 1.26%
26,772 $8.41 Million
Q3 2021

Oct 13, 2021

BUY
$274.82 - $308.34 $79,697 - $89,418
290 Added 1.08%
27,115 $7.63 Million
Q2 2021

Jul 15, 2021

SELL
$251.87 - $278.14 $98,229 - $108,474
-390 Reduced 1.43%
26,825 $7.4 Million
Q1 2021

Apr 05, 2021

SELL
$204.88 - $255.03 $73,347 - $91,300
-358 Reduced 1.3%
27,215 $6.94 Million
Q4 2020

Jan 12, 2021

SELL
$186.91 - $214.42 $9,719 - $11,149
-52 Reduced 0.19%
27,573 $5.61 Million
Q3 2020

Dec 03, 2020

BUY
$167.03 - $201.3 $6,681 - $8,052
40 Added 0.15%
27,625 $5.2 Million
Q2 2020

Jul 09, 2020

BUY
$113.31 - $182.44 $74,784 - $120,410
660 Added 2.45%
27,585 $4.58 Million
Q1 2020

Apr 13, 2020

SELL
$104.32 - $195.28 $209,891 - $392,903
-2,012 Reduced 6.95%
26,925 $3.4 Million
Q4 2019

Jan 29, 2020

BUY
$163.48 - $173.61 $193,560 - $205,554
1,184 Added 4.27%
28,937 $4.9 Million
Q3 2019

Nov 04, 2019

SELL
$159.77 - $178.1 $32,752 - $36,510
-205 Reduced 0.73%
27,753 $4.66 Million
Q2 2019

Aug 01, 2019

BUY
$144.16 - $172.9 $139,835 - $167,713
970 Added 3.59%
27,958 $4.83 Million
Q1 2019

Apr 29, 2019

BUY
$123.7 - $156.3 $120,607 - $152,392
975 Added 3.75%
26,988 $4.13 Million
Q4 2018

Feb 07, 2019

BUY
$120.82 - $174.09 $169,872 - $244,770
1,406 Added 5.71%
26,013 $3.29 Million
Q3 2018

Oct 23, 2018

BUY
$167.67 - $188.27 $174,879 - $196,365
1,043 Added 4.43%
24,607 $4.27 Million
Q2 2018

Jul 19, 2018

BUY
$160.33 - $189.41 $51,786 - $61,179
323 Added 1.39%
23,564 $4.23 Million
Q1 2018

Apr 30, 2018

SELL
$161.53 - $178.11 $23,906 - $26,360
-148 Reduced 0.63%
23,241 $3.76 Million
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $216,953 - $240,350
1,466 Added 6.69%
23,389 $3.68 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $3.28 Million - $3.52 Million
21,923
21,923 $3.31 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Jacobs & CO Portfolio

Follow Jacobs & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.